Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($) |
Jul. 02, 2025 |
Sep. 30, 2024 |
Sep. 30, 2023 |
|---|---|---|---|
| Organizational costs/startup expenses | $ 509 | ||
| Total deferred tax asset | 509 | ||
| Valuation allowance | (509) | ||
| Deferred tax asset, net of allowance | |||
| Sonnet BioTherapeutics Holdings, Inc. [Member] | |||
| Organizational costs/startup expenses | $ 26,754,767 | $ 27,996,751 | |
| Research and development credit carryforwards | 3,129,222 | 3,106,675 | |
| Amortization | 5,791,883 | 4,692,227 | |
| Share-based compensation | 19,357 | 226 | |
| Operating lease liability | 36,786 | 57,319 | |
| Accrued expenses and other | 26,977 | 546,612 | |
| Section 163(j) disallowed interest expense | 761,450 | 763,172 | |
| Total deferred tax asset | 36,520,442 | 37,162,982 | |
| Valuation allowance | (36,480,967) | (37,100,582) | |
| Deferred tax assets | 39,475 | 62,400 | |
| Property and equipment | (4,782) | (7,954) | |
| Operating lease right-of-use asset | (34,693) | (54,446) | |
| Deferred tax asset, net of allowance |
| X | ||||||||||
- Definition Deferred tax assets amortization. No definition available.
|
| X | ||||||||||
- Definition Deferred tax assets operting lease liability. No definition available.
|
| X | ||||||||||
- Definition Deferred tax assets tax deferred expense section disallowed interest expense. No definition available.
|
| X | ||||||||||
- Definition Deferred tax liabilities right of use asset. No definition available.
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|